ClinicalTrials.gg
CompletedNCT06697171Updated Aug 6, 2025

Effectiveness of Conflict-of-interest Disclosures on Trust, Credibility and Transparency When Displayed on Social Media Posts From Registered Dietitians

An interventional study of Group 1 Not an ad disclosure and Group 2 Basic Disclosure in Registered Dietitian, Conflict of Interest and Trust, sponsored by University of Ontario Institute of Technology. Completed at 1 site in Canada. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-08-06.

Sponsored by University of Ontario Institute of Technology · Not applicable, Interventional, and Other

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
3,409
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

There is limited research to inform policies and guidelines related to disclosing conflicts of interest on social media by healthcare professionals, including Registered Dietitians (RDs). This trial investigates mock social media posts by an RD to examine the impact of varying forms of conflict-of-interest (COI) disclosures. The disclosures tested are based on the Canadian Ad Standards "Influencer Marketing Disclosure Guidelines" and are incorporated into recommendations established by the provincial dietetic regulatory bodies for RDs. Specific outcomes evaluated include the public's ability to identify a COI; trust in the RD; credibility of the RD; transparency of the social media post and; purchasing and consumption intentions of the product endorsed by an RD in the post.

Read the detailed description

This study is a randomized controlled experiment embedded within an online cross-sectional survey entitled the Canadian Nutrition and Health Survey (CNHS). A sample of 3,380 Canadian adults from all Canadian provinces (ages ≥18 years, who own a computer, and have an email address) will be recruited by Leger Marketing Inc. as part of the CNHS. Participants will be randomized to one of five experimental groups that include a mock social media post with different variations of COI reporting, based on the Ad Standards (of Canada) Influencer Marketing Disclosure Guidelines. Each participant will be randomized to view one version (group) of the mock Instagram post, all of which feature the same RD promoting the nutritional benefits of a mock soy milk product. Participants will also have the opportunity to view the RD's Instagram account profile, which is consistent across all experimental groups. All participants will have as much time as needed to view the post and account profile.

As stated previously, the experimental groups vary by the extent to which the conflict of interest is reported (see below):

  • Group 1 Not an ad disclosure: COI disclosure includes @brandname and #NotAnAd in the narrative body of the social media post.
  • Group 2 Basic Disclosure: COI disclosure includes @brandname and #ad in the narrative body of the social media post.
  • Group 3 Basic + Paid Partnership Disclosure: COI disclosure accompanied by a branded "paid partnership" in the header and a tag for the industry partner, @brandname and #ad immediately at the beginning of the post, and #ad and #sponsored at the bottom of the narrative body of the social media post.
  • Group 4 Basic + Paid Partnership + Image label: COI disclosure includes the same characteristics as Group 3, with the addition of #ad appearing on the post image itself.
  • Group 5 Control group: is a control with no COI disclosure elements (i.e. no hashtags and only the @brandname included within the narrative body of the social media post).

The primary outcome is the ability of a participant to identify if COI disclosures exist within the social media post. The secondary outcomes include participants' trust in the RD in the social media post, credibility of the RD in the social media post, participants' buying and consumption intentions, and transparency of COI reporting by the RD. Tertiary outcomes include the participants' recommendation of the food item endorsed by the RD to others, participants' engagement with the social media post, and participants' view of the healthfulness of a product endorsed by the RD.

It is hypothesized that, compared to the control condition, participants will rate all experimental conditions as having a conflict of interest. The experimental conditions will be rated more transparent and trustworthy, with the RD in the social media post being rated as more credible, and with greater purchasing/consumption intentions.

02

Conditions studied

  • Registered Dietitian
  • Conflict of Interest
  • Trust
  • Credibility
  • Transparency

Keywords

  • Registered Dietitian
  • Conflict of Interest
03

In context

Lead sponsor

University of Ontario Institute of Technology is the lead sponsor of 9 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

Inclusion Criteria:

Participants are included if:

  • are ≥18 years
  • own a computer,
  • have an email address
  • speak/write in English/French
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
3,409 participants (actual)

Study arms

  • Active comparator
    Control

    No COI Disclosure (Control). Only @brandname is tagged in the social media post narrative body.

    Other: Control

  • Experimental
    Group 1 Not an Ad Disclosure

    Disclosure includes @brandname and #NotAnAd in the social media post narrative body.

    Other: Group 1 Not an ad disclosure

  • Experimental
    Group 2 Basic Disclosure

    Disclosure includes @brandname and #ad in the narrative body of the social media post.

    Other: Group 2 Basic Disclosure

  • Experimental
    Group 3 Basic + Paid Partnership Disclosure

    Disclosure includes a branded "paid partnership" in the header and a tag for the industry partner, @brandname and #ad immediately at the beginning of the post, and #ad and #sponsored at the bottom of the narrative body of the social media post.

    Other: Group 3 Basic + Paid Partnership Disclosure

  • Experimental
    Group 4 Basic + Paid Partnership + Image label

    Disclosure includes the same attributes as Group 3, with the addition of #ad appearing on the post image itself.

    Other: Group 4 Basic + Paid Partnership + Image label

Interventions

  • OtherGroup 1 Not an ad disclosure

    Same social media post viewed as all other groups. @brandname in the narrative body of the social media post; #NotAnAd in the narrative body of the social media post

  • OtherGroup 2 Basic Disclosure

    Same social media post viewed as all other groups. @brandname in the narrative body of the social media post; #ad in the narrative body of the social media post

  • OtherGroup 3 Basic + Paid Partnership Disclosure

    Same social media post viewed as all other groups. COI disclosures include "paid partnership" in the header and a tag for the industry partner; @brandname and #ad immediately at the beginning of the narrative body of the social media post; #ad and #sponsored at the bottom of the narrative body of the social media post.

  • OtherControl

    No COI disclosure elements (i.e. no hashtags ). Only the @brandname is included within the narrative body of the social media post.

  • OtherGroup 4 Basic + Paid Partnership + Image label

    Same social media post viewed as all other groups. COI disclosures include "paid partnership" in the header and a tag for the industry partner; @brandname and #ad immediately at the beginning of the narrative body of the social media post; #ad and #sponsored at the bottom of the narrative body of the social media post; #ad (black text, white background) appears on the photo associated with the social media post

06

What researchers measure

Primary outcomes

  1. Conflict of Interest

    Participant identification of COI will be: * Assessed by the statement "I believe the person in the post has a conflict of interest" * Evaluated on a 5-point Likert Scale from Strongly Disagree (1) to Strongly Agree (5). There is no "not applicable" option.

    Time frame: Measured after 5-10 minutes of exposure to the social media post

Secondary outcomes

  1. Trust

    •Trust of the RDs post will be: * Assessed by the statements "I trust the person in this post" and "I believe the post is true". This is also assessed using an open-ended question. * Evaluated on a 5-point Likert Scale from Strongly Disagree (1) to Strongly Agree (5). There is no "not applicable" option.

    Time frame: Measured after 5-10 minutes of exposure to the social media post

  2. Credibility

    • The RD's credibility will be: * Assessed by the statement "The person in this post is qualified to provide this information". * Evaluated on a 5-point Likert Scale from Strongly Disagree (1) to Strongly Agree (5). There is no "not applicable" option.

    Time frame: Measured after 5-10 minutes of exposure to the social media post

  3. Purchasing Intentions

    • The participants' purchasing intentions of a product after viewing the post will be: * Assessed by the statement: How likely you would "Buy the food item in the post" and "I am more likely to buy a product if a Registered Dietitian has endorsed it" (both will be reviewed separately) * Evaluated on a 5-point Likert Scale from Very Unlikely (1) to Very Likely (5). There is no "not applicable" option.

    Time frame: Measured after 5-10 minutes of exposure to the social media post

  4. Consumption Intentions

    • The participants' consumption intentions of a product after seeing the RDs post will be: * Assessed by the statement: How likely you would "Consume the food item in the post" * Evaluated on a 5-point Likert Scale from Very Unlikely (1) to Very Likely (5). There is no "not applicable" option.

    Time frame: Measured after 5-10 minutes of exposure to the social media post

  5. Transparency

    • Transparency of the RDs post will be: * Assessed by the statement "The food item is being endorsed" * Evaluated on a 5-point Likert Scale from Strongly Disagree (1) to Strongly Agree (5). There is no "not applicable" option.

    Time frame: Measured after 5-10 minutes of exposure to the social media post

Other outcomes

  1. Recommendation

    • Participants' recommendation a product endorsed by an RD will be: * Assessed by the statement "Recommend the food item in the post to others (e.g., family, friends)" * Evaluated on a 5-point Likert Scale from Very Unlikely (1) to Very Likely (5). There is no "not applicable" option.

    Time frame: Measured after 5-10 minutes of exposure to the social media post

  2. Engagement with the post

    • Participants' engagement with the social media post by an RD: * Assessed by the statement, "Like, comment or share this post on social media" * Evaluated on a 5-point Likert Scale from Very Unlikely (1) to Very Likely (5). There is no "not applicable" option.

    Time frame: Measured after 5-10 minutes of exposure to the social media post

  3. Healthfulness

    • Participants' view of healthfulness of a product will be: * Assessed by the statements, "How healthy do you think soy milk is" and "After reviewing the post, how healthy do you think soy milk is?" * Evaluated on a 5-point Likert Scale from Not at all healthy (1) to Very healthy (5). There is no "not applicable" option.

    Time frame: Measured after 5-10 minutes of exposure to the social media post

  4. Frequency

    Frequency of consumption of soy milk was: * Assessed by the statement "How often do you have soy milk?" * Evaluated on a 5-point Likert Scale from Never (1) to Always (5). There is no "not applicable" option.

    Time frame: Measured after 5-10 minutes of exposure to the social media post

07

Study locations

1 site
  • University of Ontario Institute of Technology
    Oshawa, Ontario L1G 0C5, Canada
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Oct 2024 to primary completion in Nov 2024, 0 months.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 13, 2024
First posted
Nov 20, 2024
StartActual
Oct 28, 2024
Primary completionActual
Nov 24, 2024
CompletionActual
Nov 24, 2024
Last update
Aug 6, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 6, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06697171
Lead sponsor
University of Ontario Institute of Technology
Responsible party
JoAnne Arcand (Principal Investigator, University of Ontario Institute of Technology) — Principal investigator
First posted
Nov 20, 2024
Start date
Oct 28, 2024
Primary completion
Nov 24, 2024
Completion
Nov 24, 2024
Last update
Aug 6, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion